Publications by authors named "Toshibumi Taniguchi"

Objectives: Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of CAB+RPV in people with HIV in Japan, focusing on virological outcomes, treatment continuation and inflammatory markers, providing valuable insight into the use of injectable regimens in clinical practice.

Methods: This multicentre retrospective study analysed routinely collected data from eight HIV centres in Japan on people with HIV who initiated CAB+RPV before January 2024.

View Article and Find Full Text PDF

Otitis externa is an ear disease that is present in 10-20% of dogs. Bacterial organisms are a common cause, and infection may cause severe and chronic inflammation. Thus, there is a need for early detection and identification of bacteria in ear discharge samples.

View Article and Find Full Text PDF

Brucella anthropi, an aerobic, glucose-nonfermenting gram-negative rod, is predominantly an opportunistic pathogen affecting immunosuppressed patients. This case report describes a 27-year-old woman with systemic lupus erythematosus who developed persistent B. anthropi bacteremia following a pregnancy termination.

View Article and Find Full Text PDF

The effect of the antibodies elicited by bivalent mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (the original strain and Omicron variant BA.1) on preventing coronavirus disease 2019 (COVID-19) onset during the XBB variant dominance remains unknown. We conducted a prospective cohort study at Chiba University Hospital and examined healthcare workers who received the Pfizer-BioNTech bivalent mRNA COVID-19 vaccine (targeting the original and Omicron BA.

View Article and Find Full Text PDF

Staphylococcus aureus can cause outbreaks and becomes multi-drug resistant through gene mutations and acquiring resistance genes. However, why S. aureus easily adapts to hospital environments, promoting resistance and recurrent infections, remains unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Tixagevimab/cilgavimab is a monoclonal antibody treatment approved for preventing COVID-19 in high-risk, immunocompromised patients.
  • A study analyzed data from 397 patients in Japan who received this treatment, focusing on their demographics and health outcomes over six months.
  • The findings highlighted that many patients had serious health issues like cancer or heart disease, and the rates of COVID-related hospitalization and death were relatively low among those treated with the antibodies.
View Article and Find Full Text PDF

Numerous SARS-CoV-2 variant strains with altered characteristics have emerged since the onset of the COVID-19 pandemic. Remdesivir (RDV), a ribonucleotide analogue inhibitor of viral RNA polymerase, has become a valuable therapeutic agent. However, immunosuppressed hosts may respond inadequately to RDV and develop chronic persistent infections.

View Article and Find Full Text PDF

We report the case of an 84-year-old man with a history of IgG4-related sclerosing cholangitis who was diagnosed with advanced esophageal cancer and underwent radiation and chemotherapy. An implantable central venous access port was placed for chemotherapy and total parenteral nutrition. The patient presented with a fever and received antimicrobial therapy for acute cholangitis but remained febrile, and subsequently, yeast was detected in the aerobic bottle of blood culture obtained from the central venous line.

View Article and Find Full Text PDF

Background: Integrase strand transfer inhibitors (INSTIs) are recommended as first-line ART for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated mutation E157Q, a highly prevalent (2%-5%) polymorphism of the HIV-1 (human immunodeficiency virus type 1) integrase gene, has limited data on optimal first-line ART regimens. We assessed the virological outcomes of various first-line ART regimens in PLWH with E157Q in real-world settings.

View Article and Find Full Text PDF

Background: While global efforts have been made to prevent transmission of HIV, the epidemic persists. Men who have sex with men (MSM) are at high risk of infection. Despite evidence of its cost-effectiveness in other jurisdictions, pre-exposure prophylaxis (PrEP) for MSM is neither approved nor reimbursed in Japan.

View Article and Find Full Text PDF
Article Synopsis
  • - Late HIV diagnosis in Japan is a significant issue, particularly among young men who have sex with men (MSM) in urban areas, and the study aimed to understand various factors contributing to this problem, including demographics and clinical aspects.
  • - The research analyzed anonymized data from nearly 10,000 newly diagnosed HIV cases from 2003 to 2019, revealing that 71.2% of participants experienced late diagnosis, with a median CD4 count of 221 cells/μl at diagnosis.
  • - Key factors linked to late HIV diagnosis included older age, heterosexual transmission, living outside of Tokyo, co-infection with hepatitis C, and not being part of a genetic cluster, while a specific HIV subtype (CRF
View Article and Find Full Text PDF

Objective A T-SPOT.TB can yield indeterminate results under two test observation conditions: a high response to the nil in negative control wells (high nil-control) or a low response to the mitogen in positive control wells (low mitogen-control). The most strongly influential factors for these indeterminate results, however, have yet to be identified.

View Article and Find Full Text PDF

Symptoms of adverse reactions to vaccines evolve over time, but traditional studies have focused only on the frequency and intensity of symptoms. Here, we attempt to extract the dynamic changes in vaccine adverse reaction symptoms as a small number of interpretable components by using non-negative tensor factorization. We recruited healthcare workers who received two doses of the BNT162b2 mRNA COVID-19 vaccine at Chiba University Hospital and collected information on adverse reactions using a smartphone/web-based platform.

View Article and Find Full Text PDF

Background: Tracking SARS-CoV-2 variants of concern (VOC) by genomic sequencing is time-consuming. The rapid screening of VOCs is necessary for clinical laboratories. In this study, we developed a rapid screening method based on multiplex RT-PCR by extended S-gene target failure (eSGTF), a false negative result caused by S-gene mutations.

View Article and Find Full Text PDF

Introduction: Vaccine effectiveness against SARS-CoV-2 infections decreases due to waning immunity, and booster vaccination was therefore introduced. We estimated the anti-spike antibody (AS-ab) recovery by booster vaccination and analyzed the risk factors for SARS-CoV-2 infections.

Methods: The subjects were health care workers (HCWs) in a Chiba University Hospital vaccination cohort.

View Article and Find Full Text PDF

BACKGROUND Although sotrovimab reduces the risk of hospitalization or death due to COVID-19, there have been few reports of its use in clinical practice. Particularly, information on the effectiveness of sotrovimab against the omicron variant of the virus is limited. We present 10 cases of COVID-19 treated with sotrovimab at our unit between December 2021 and February 2022.

View Article and Find Full Text PDF

Legionella pneumophila (L. pneumophila) is responsible for most Legionnaire's disease cases diagnosed worldwide. The species includes 16 serogroups, but most Legionnaire's disease cases (85.

View Article and Find Full Text PDF

Background: Coronavirus disease (COVID-19) has induced an urgent need to train medical students not only in infection prevention control but also in the treatment of infectious diseases, including COVID-19. This study evaluates the impact of simulated clinical practice with peer role-plays and a lecture on clinical education for COVID-19.

Methods: The sample for the study included 82 fourth- and fifth-year medical students undergoing clinical clerkship in respiratory medicine.

View Article and Find Full Text PDF

Introduction: Genomic surveillance of the SARS-CoV-2 virus is important to assess transmissibility, disease severity, and vaccine effectiveness. The SARS-CoV-2 genome consists of approximately 30 kb single-stranded RNA that is too large to analyze the whole genome by Sanger sequencing. Thus, in this study, we performed Sanger sequencing following long-range RT-PCR of the entire SARS-CoV-2 S-gene and analyzed the mutational dynamics.

View Article and Find Full Text PDF

Introduction: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of Comirnaty®️.

Methods: Healthcare workers (HCWs) who were vaccinated with Comirnaty®️ were asked to register for the application software and to report AEs for 14 days after vaccination.

View Article and Find Full Text PDF